David M. O'Malley, MD
Assistant Professor
The Ohio State University
Dept. of OB/GYN
M210 Starling-Loving
320 West Tenth Ave.
Columbus,
OH
USA
43210
Biographical Sketch: over 50 peer reviewed publication, national clinical trial PI"
Papers:
2 - Scientific Plenary
A randomized phase III trial of gemcitabine + docetaxel + bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma (uLMS): a Gynecologic Oncology Group study
139 - Scientific Plenary
Health-related quality of life associated with every-3-week paclitaxel vs dose-dense weekly paclitaxel in combination with carboplatin with or without bevacizumab for primary ovarian cancer: Gynecologic Oncology Group study 262
393 - Poster Session B
Risk of complications after robotic hysterectomy for endometrial cancer in obese patients with preoperative comorbidities
402 - Poster Session B
Bariatric surgery of a means to decrease mortality in women with type I endometrial cancer: an intriguing option in a population at risk for dying of complications of metabolic syndrome
516 - Poster Session B
Outpatient rapid desensitization for gynecologic oncology patients with mild to moderate hypersensitivity reactions to platinums
Late Breaking Abstract 1
A Randomized Phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group tr